Registro:

Referencias:

• Atkinson, M.A., Maclaren, N.K., The pathogenesis of insulin-dependent diabetes mellitus (1994) N Engl J Med, 331, pp. 1428-1436
• Roep, B.O., Kallan, A.A., De Vries, R.R., Beta-cell antigen-specific lysis of macrophages by CD4 T-cell clones from newly diagnosed IDDM patient. A putative mechanism of T-cell-mediated autoimmune islet cell destruction (1992) Diabetes, 41, pp. 1380-1384
• Davidson, M.H., Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist (2012) Am J Cardiol, 110, pp. 43B-449
• Reimann, M., Bonifacio, E., Solimena, M., An update on preventive and regenerative therapies in diabetes mellitus (2009) Pharmacol Ther, 121, pp. 317-331
• Sosenko, J.M., Skyler, J.S., Palmer, J.P., The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients (2013) Diabetes Care, 36, pp. 2615-2620
• Aggarwal, B.B., Harikumar, K.B., Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases (2009) Int J Biochem Cell Biol, 41, pp. 40-59
• Natarajan, C., Bright, J.J., Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes (2002) J Immunol, 168, pp. 6506-6513
• Motawi, T.K., Rizk, S.M., Shehata, A.H., Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease (2012) J Physiol Biochem, 68, pp. 529-539
• Chandran, B., Goel, A., A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis (2012) Phytother Res, 26, pp. 1719-1725
• Sun, J., Zhao, Y., Hu, J., Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice (2013) PLOS ONE, 8, pp. e67078
• Hatcher, H., Planalp, R., Cho, J., Torti, F.M., Torti, S.V., Curcumin: from ancient medicine to current clinical trials (2008) Cell Mol Life Sci, 65, pp. 1631-1652
• Curic, S., Wu, Y., Shan, B., Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas (2013) J Neurooncol, 113, pp. 385-396
• Shishodia, S., Sethi, G., Aggarwal, B.B., Curcumin: getting back to the roots (2005) Ann NY Acad Sci, 1056, pp. 206-217
• Soetikno, V., Sari, F.R., Veeraveedu, P.T., Curcumin ameliorates macrophage infiltration by inhibiting NF-kappaB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy (2011) Nutr Metab (Lond), 8, p. 35
• Weisberg, S.P., Leibel, R., Tortoriello, D.V., Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity (2008) Endocrinology, 149, pp. 3549-3558
• Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C., Jirawatnotai, S., Curcumin extract for prevention of type 2 diabetes (2012) Diabetes Care, 35, pp. 2121-2127
• Kanai, M., Yoshimura, K., Asada, M., A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer (2011) Cancer Chemother Pharmacol, 68, pp. 157-164
• Kanai, M., Otsuka, Y., Otsuka, K., A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients (2013) Cancer Chemother Pharmacol, 71, pp. 1521-1530
• Kanitkar, M., Gokhale, K., Galande, S., Bhonde, R.R., Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo (2008) Br J Pharmacol, 155, pp. 702-713
• Chanpoo, M., Petchpiboonthai, H., Panyarachun, B., Anupunpisit, V., Effect of curcumin in the amelioration of pancreatic islets in streptozotocin-induced diabetic mice (2010) J Med Assoc Thai, 93 (SUPPL. 6), pp. S152-S159
• Driver, J.P., Serreze, D.V., Chen, Y.G., Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease (2011) Semin Immunopathol, 33, pp. 67-87
• Perone, M.J., Bertera, S., Tawadrous, Z.S., Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice (2006) J Immunol, 177, pp. 5278-5289
• Liberman, A.C., Antunica-Noguerol, M., Ferraz-de-Paula, V., Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells (2012) PLOS ONE, 7, pp. e35155
• Liberman, A.C., Refojo, D., Druker, J., The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction (2007) FASEB J, 21, pp. 1177-1188
• Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., Glimcher, L.H., A novel transcription factor, T-bet, directs Th1 lineage commitment (2000) Cell, 100, pp. 655-669
• Perone, M.J., Larregina, A.T., Shufesky, W.J., Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells (2006) J Immunol, 176, pp. 7207-7220
• Augstein, P., Elefanty, A.G., Allison, J., Harrison, L.C., Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes (1998) Diabetologia, 41, pp. 1381-1388
• Piganelli, J.D., Flores, S.C., Cruz, C., A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone (2002) Diabetes, 51, pp. 347-355
• Roep, B.O., De Vries, R.R., T-lymphocytes and the pathogenesis of type 1 (insulin-dependent) diabetes mellitus (1992) Eur J Clin Invest, 22, pp. 697-711
• Steinman, R.M., Nussenzweig, M.C., Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance (2002) Proc Natl Acad Sci USA, 99, pp. 351-358
• Barcala Tabarrozzi, A.E., Castro, C.N., Dewey, R.A., Sogayar, M.C., Labriola, L., Perone, M.J., Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus (2013) Clin Exp Immunol, 171, pp. 135-146
• Brouet, I., Ohshima, H., Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages (1995) Biochem Biophys Res Commun, 206, pp. 533-540
• Like, A.A., Rossini, A.A., Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus (1976) Science, 193, pp. 415-417
• Liu, L., Liu, Y.L., Liu, G.X., Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway (2013) Int Immunopharmacol, 17, pp. 314-320
• Ramirez-Tortosa, M.C., Mesa, M.D., Aguilera, M.C., Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis (1999) Atherosclerosis, 147, pp. 371-378
• Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., Cole, G.M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse (2001) J Neurosci, 21, pp. 8370-8377
• Joe, B., Rao, U.J., Lokesh, B.R., Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin (1997) Mol Cell Biochem, 169, pp. 125-134
• Deodhar, S.D., Sethi, R., Srimal, R.C., Preliminary study on antirheumatic activity of curcumin (diferuloyl methane) (1980) Indian J Med Res, 71, pp. 632-634
• Katz, J.D., Benoist, C., Mathis, D., T helper cell subsets in insulin-dependent diabetes (1995) Science, 268, pp. 1185-1188
• Perone, M.J., Bertera, S., Shufesky, W.J., Suppression of autoimmune diabetes by soluble galectin-1 (2009) J Immunol, 182, pp. 2641-2653
• Fahey, A.J., Adrian Robins, R., Constantinescu, C.S., Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells (2007) J Cell Mol Med, 11, pp. 1129-1137
• Williams, C.L., Schilling, M.M., Cho, S.H., STAT4 and T-bet are required for the plasticity of IFN-gamma expression across Th2 ontogeny and influence changes in ifng promoter DNA methylation (2013) J Immunol, 191, pp. 678-687
• Martin-Orozco, N., Chung, Y., Chang, S.H., Wang, Y.H., Dong, C., Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells (2009) Eur J Immunol, 39, pp. 216-224
• Bending, D., De la Pena, H., Veldhoen, M., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice (2009) J Clin Invest, 119, pp. 565-572
• Poligone, B., Weaver Jr, D.J., Sen, P., Baldwin Jr, A.S., Tisch, R., Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function (2002) J Immunol, 168, pp. 188-196
• Rescigno, M., Martino, M., Sutherland, C.L., Gold, M.R., Ricciardi-Castagnoli, P., Dendritic cell survival and maturation are regulated by different signaling pathways (1998) J Exp Med, 188, pp. 2175-2180
• Kim, G.Y., Kim, K.H., Lee, S.H., Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets (2005) J Immunol, 174, pp. 8116-8124
• Kang, B.Y., Chung, S.W., Chung, W., Im, S., Hwang, S.Y., Kim, T.S., Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin (1999) Eur J Pharmacol, 384, pp. 191-195
• Kang, B.Y., Song, Y.J., Kim, K.M., Choe, Y.K., Hwang, S.Y., Kim, T.S., Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages (1999) Br J Pharmacol, 128, pp. 380-384
• Alleva, D.G., Pavlovich, R.P., Grant, C., Kaser, S.B., Beller, D.I., Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice (2000) Diabetes, 49, pp. 1106-1115
• Marleau, A.M., Singh, B., Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1-inducing abilities (2002) J Autoimmun, 19, pp. 23-35
• Morin, J., Faideau, B., Gagnerault, M.C., Lepault, F., Boitard, C., Boudaly, S., Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice (2003) Clin Exp Immunol, 134, pp. 388-395
• Shehzad, A., Lee, Y.S., Molecular mechanisms of curcumin action: signal transduction (2013) Biofactors, 39, pp. 27-36
• Rogers, N.M., Kireta, S., Coates, P.T., Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo (2010) Clin Exp Immunol, 162, pp. 460-473
• Gerondakis, S., Siebenlist, U., Roles of the NF-kappaB pathway in lymphocyte development and function (2010) Cold Spring Harbor Perspect Biol, 2, pp. a000182
• Curtsinger, J.M., Schmidt, C.S., Mondino, A., Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells (1999) J Immunol, 162, pp. 3256-3262
• Pape, K.A., Khoruts, A., Mondino, A., Jenkins, M.K., Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells (1997) J Immunol, 159, pp. 591-598
• Tse, H.M., Milton, M.J., Schreiner, S., Profozich, J.L., Trucco, M., Piganelli, J.D., Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness (2007) J Immunol, 178, pp. 908-917
• Xavier, S., Sadanandan, J., George, N., Paulose, C.S., Beta(2)-adrenoceptor and insulin receptor expression in the skeletal muscle of streptozotocin induced diabetic rats: antagonism by vitamin D(3) and curcumin (2012) Eur J Pharmacol, 687, pp. 14-20

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------